Marcel Stoeckle Selected Research

Marcel Stoeckle Research Topics

Disease

5	Infections 01/2021 - 01/2015
5	COVID-19 01/2021 - 01/2020
3	HIV Infections (HIV Infection) 12/2019 - 01/2015
2	Leishmaniasis 10/2013 - 03/2012
1	Spontaneous Abortion (Miscarriage) 01/2022
1	Inflammation (Inflammations) 01/2020
1	Chronic Disease (Chronic Diseases) 12/2019
1	Viremia 10/2019
1	Yellow Fever 01/2018
1	Disease Progression 01/2017
1	Dementia (Dementias) 01/2017
1	Esophagitis 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 07/2015
1	Neoplasms (Cancer) 03/2015
1	Second Primary Neoplasms (Neoplasms, Second) 03/2015
1	Hodgkin Disease (Hodgkin's Disease) 03/2015
1	Chronic Hepatitis C 01/2015
1	Venous Thromboembolism 01/2014
1	Hemorrhage 01/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2014
1	Opportunistic Infections (Opportunistic Infection) 01/2014
1	Cutaneous Leishmaniasis 10/2013
1	Erectile Dysfunction 01/2013
1	Hypokalemia 03/2012
1	Obesity 01/2012
1	Pruritus (Itching) 01/2010

Drug/Important Bio-Agent (IBA)

4	Lopinavir FDA Link 01/2021 - 01/2020
4	Pharmaceutical PreparationsIBA 10/2020 - 03/2015
4	RNA (Ribonucleic Acid)IBA 01/2018 - 07/2015
2	Ritonavir (Norvir)FDA Link 11/2020 - 10/2020
2	etravirine (TMC-125)FDA Link 07/2015 - 03/2015
2	Protease Inhibitors (Protease Inhibitor)IBA 07/2015 - 03/2015
2	miltefosine (Impavido)IBA 10/2013 - 03/2012
1	tocilizumab (atlizumab)FDA Link 01/2021
1	Immunoglobulin G (IgG)IBA 11/2020
1	EnzymesIBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2020
1	CytokinesIBA 01/2020
1	Cytochrome P-450 CYP3AIBA 01/2020
1	dolutegravirIBA 10/2019
1	lamivudine drug combination abacavir FDA Link 10/2019
1	Antiviral Agents (Antivirals)IBA 07/2018
1	Tenofovir (Viread)FDA Link 01/2017
1	Rilpivirine (TMC-278)IBA 01/2017
1	Emtricitabine (Emtriva)FDA Link 01/2017
1	TabletsIBA 01/2017
1	tenofovir alafenamideIBA 01/2017
1	Interleukin-17 (Interleukin 17)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 07/2015
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2015
1	efavirenz (Sustiva)FDA Link 07/2015
1	LipidsIBA 07/2015
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 03/2015
1	Antineoplastic Agents (Antineoplastics)IBA 03/2015
1	InterferonsIBA 01/2015
1	Ribavirin (Virazole)FDA LinkGeneric 01/2015
1	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 01/2015
1	telaprevirIBA 01/2015
1	RivaroxabanIBA 01/2014
1	Meglumine AntimoniateIBA 03/2012
1	SteroidsIBA 01/2010
1	Promethazine (Promet)FDA LinkGeneric 01/2010

Therapy/Procedure

10	Therapeutics 11/2020 - 01/2012
2	Highly Active Antiretroviral Therapy (HAART) 01/2016 - 01/2014
1	Induced Abortion (Induced Abortions) 01/2022
1	Chemoprevention 11/2020
1	Drug Therapy (Chemotherapy) 03/2015
1	Salvage Therapy 01/2014